KRAS oncogene mutations are commonly encountered in pancreatic ductal adenocarcinoma, driving tumour initiation, proliferation, progression and metastasis. Human exosomes engineered to deliver small interfering RNA silencing KRASG12D are highly efficient at specifically targeting pancreatic cancer cells to dramatically reduce RAS activation, cancer cell proliferation and metastatic processes.
机构:
Fujian Med Univ, Fac Pharm, Dept Pharmaceut Anal, Fuzhou 350108, Fujian, Peoples R China
Putian Univ, Pharm & Med Technol Sch, Dept Pharm, Putian 351100, Fujian, Peoples R ChinaFujian Med Univ, Fac Pharm, Dept Pharmaceut Anal, Fuzhou 350108, Fujian, Peoples R China
Zhao, Chengfei
Gao, Feng
论文数: 0引用数: 0
h-index: 0
机构:
Fujian Med Univ, Affiliated Hosp 1, Dept Pathol, Fuzhou 350005, Fujian, Peoples R ChinaFujian Med Univ, Fac Pharm, Dept Pharmaceut Anal, Fuzhou 350108, Fujian, Peoples R China
Gao, Feng
Weng, Shaohuang
论文数: 0引用数: 0
h-index: 0
机构:
Fujian Med Univ, Fac Pharm, Dept Pharmaceut Anal, Fuzhou 350108, Fujian, Peoples R ChinaFujian Med Univ, Fac Pharm, Dept Pharmaceut Anal, Fuzhou 350108, Fujian, Peoples R China
Weng, Shaohuang
Liu, Qicai
论文数: 0引用数: 0
h-index: 0
机构:
Fujian Med Univ, Affiliated Hosp 1, Dept Clin Lab, Fuzhou 350005, Fujian, Peoples R ChinaFujian Med Univ, Fac Pharm, Dept Pharmaceut Anal, Fuzhou 350108, Fujian, Peoples R China